Medicare and Medicare Advantage Coverage Policies for Ketamine Therapy
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901819380203520 |
|---|---|
| author | Alvear, Michael |
| author_facet | Alvear, Michael |
| contents | <p dir="ltr">This dataset shows 2025 Medicare Advantage enrollment by parent organization. Each row lists a carrier, the number of covered lives in its MA products, its share of the national MA market, and the cumulative share when ranked from largest to smallest. Source fields document whether the figure comes from KFF’s July 2025 national enrollment update or from CMS’s August 2025 Monthly Enrollment by Contract file.</p> <p> </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17049243 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Medicare and Medicare Advantage Coverage Policies for Ketamine Therapy Alvear, Michael Medicare medicare advantage ketamine therapy spravato iv ketamine <p dir="ltr">This dataset shows 2025 Medicare Advantage enrollment by parent organization. Each row lists a carrier, the number of covered lives in its MA products, its share of the national MA market, and the cumulative share when ranked from largest to smallest. Source fields document whether the figure comes from KFF’s July 2025 national enrollment update or from CMS’s August 2025 Monthly Enrollment by Contract file.</p> <p> </p> |
| title | Medicare and Medicare Advantage Coverage Policies for Ketamine Therapy |
| topic | Medicare medicare advantage ketamine therapy spravato iv ketamine |
| url | https://doi.org/10.5281/zenodo.17049243 |